Table 3.
Prostate cancer age-standardized incidence rates (ASRw) and age-specific rates per 100 000 men in Lebanon compared to MENA and non-MENA countries.
| Country | Year(s) | ASRw | 40–44y | 45–49y | 50–54y | 55–59y | 60–64y | 65–69y | 70–74y | 75+y | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MENA countries | Lebanon 20 | 2012 | 41.3 | 3.6 | 12.2 | 47.5 | 95.5 | 133.3 | 291.5 | 441.4 | 559.5 |
| Israeli non-Jews 26 | 2012 | 41.9 | 1.7 | 1.9 | 49.6 | 118.8 | 144.9 | 297.5 | 488.1 | 498.6 | |
| Israeli Jews 26 | 2012 | 55.8 | 1.7 | 9.4 | 59.8 | 136.1 | 283.2 | 480.5 | 601.2 | 443.7 | |
| Jordan 28 | 2012 | 12.7 | 0 | 3.7 | 4.9 | 20.0 | 27.5 | 94.6 | 170.0 | 205.7 | |
| Egypt, Minia Governorate 29 | 2009 | 5.2 | 1.0 | - | 1.3 | 10.2 | 16.2 | 28.5 | 51.1 | 105.3 | |
| Egypt, Aswan Governorate 29 | 2008 | 9.2 | - | - | 6.6 | - | 28.4 | 37.9 | 85.4 | 237.4 | |
| Egypt, Damietta Governorate 29 | 2012 | 6.8 | - | - | 7.6 | 5.0 | 26.3 | 28.9 | 77.9 | 136.8 | |
| Kuwait: Kuwaiti 26 | 2012 | 22.4 | 3.3 | 4 | 26.7 | 14.2 | 114.6 | 89.5 | 241.1 | 398.6 | |
| Bahrain: Bahraini 26 | 2012 | 16.3 | - | 5.9 | - | 16.7 | 49.1 | 115.6 | 199.1 | 290.7 | |
| Saudi Arabia: Saudi 30 | 2013 | 5.5 | 0.2 | 0.2 | 3.8 | 8.6 | 21.7 | 35.4 | 49.5 | 100.4 | |
| Algeria, Setif 27 | 2008-2011 | 7.7 | - | 2.6 | 8.1 | 8.1 | 28.3 | 62.9 | 80.2 | 110.4 | |
| Algeria, Batna 27 | 2008-2012 | 6.5 | - | 0.7 | 2.7 | 2.3 | 29.9 | 39.3 | 60.4 | 129.8 | |
| Iran, Golestan 27 | 2008-2011 | 11.8 | 0.5 | 0.6 | 9.0 | 17.2 | 29.1 | 77.1 | 130.4 | 221.1 | |
| Non-MENA countries | Cyprus 26 | 2012 | 65.7 | - | 14.7 | 46.4 | 158 | 206.6 | 510.9 | 798.8 | 692.8 |
| Turkey (2 registries) 26 | 2012 | 40.7 | 0.4 | 7.9 | 30.2 | 103.8 | 183.4 | 354.3 | 393.3 | 443.6 | |
| USA, SEER (9 registries) 26 | 2012 | 81.3 | 41.2 | 121.4 | 257.7 | 438.3 | 681.8 | 693.4 | 583.7 | 488.6 | |
| Denmark 31 | 2012 | 78.6 | 3.6 | 16.2 | 63.1 | 177.1 | 405.6 | 657.5 | 794.4 | 765.3 | |
| Norway 26 | 2012 | 111.0 | 4.1 | 29.5 | 99.1 | 303.9 | 590.9 | 918.6 | 1054.5 | 965.4 | |
| Estonia 26 | 2012 | 107.6 | 4.4 | 33.1 | 99.6 | 302.7 | 537.8 | 1003.5 | 1018.6 | 836.0 | |
| Sweden 31 | 2012 | 92.5 | 3.4 | 21.1 | 112.6 | 268.0 | 511.7 | 763.6 | 826.1 | 736.7 | |
| UK, England 26 | 2012 | 72.9 | 3.6 | 17 | 64.3 | 175.4 | 340.3 | 578.5 | 703.3 | 812.61 | |
| Ireland 26 | 2012 | 107.9 | 8.3 | 44.4 | 145.4 | 337.2 | 647.9 | 918.2 | 890.8 | 637.52 | |
| Spain (9 registries) 26 | 2010 | 70.2 | 2.3 | 16.9 | 50.4 | 206 | 394 | 577.3 | 706.5 | 547.23 | |
| France (9 registries) 26 | 2011 | 98.4 | 2.6 | 14.8 | 111.3 | 313.8 | 549.9 | 864 | 878.6 | 677.82 | |
| Italy (8 registries) 26 | 2010 | 68.2 | 1.5 | 11.9 | 70.9 | 176.4 | 376.1 | 584.9 | 715.2 | 487.09 | |
| Belgium 32 | 2012 | 80.4 | 2.77 | 16.76 | 100.3 | 232.3 | 414.8 | 662.24 | 729.12 | 693.0 | |
| Germany (2 registries) 26 | 2012 | 59.6 | 2.9 | 13.3 | 45.2 | 166.2 | 303.9 | 486.4 | 610.2 | 518.34 | |
| Switzerland 26 | 2012 | 81.0 | 12.3 | 86.7 | 245.8 | 402.6 | 681.3 | 764.4 | 745.8 | 696.5 | |
| China (5 registries) 26 | 2012 | 17.5 | 0.2 | 1.6 | 7.1 | 18.9 | 54 | 133.3 | 229.6 | 275.13 | |
| Thailand (4 registries) 26 | 2012 | 6.6 | - | 0.5 | 2.5 | 11.3 | 25.8 | 35.7 | 82.9 | 113.3 | |
| Korea (5 registries) 26 | 2012 | 28.7 | 0.7 | 3.1 | 12.8 | 43.1 | 122 | 226.1 | 307.8 | 406.66 | |
| Japan (4 registries) 26 | 2010 | 38.0 | 0.4 | 4.1 | 17.0 | 57.0 | 149.3 | 300.0 | 467.4 | 513.3 | |
| Philippines, Manila 26 | 2012 | 22.6 | 0.5 | 1.3 | 5.1 | 19.5 | 73.8 | 91.8 | 325.2 | 459.2 | |
| Canada 26 (excl. Nunavut, Quebec and Yukon) | 2012 | 73.0 | 7 | 26.9 | 99 | 225.6 | 397.3 | 583.6 | 627.4 | 550.7 | |
| Australia 26 | 2012 | 112.3 | 12.3 | 59.7 | 152.7 | 364.6 | 612.9 | 896.0 | 900.5 | 808.3 | |
| Brazil, Goiania 26 | 2012 | 112.5 | 2.2 | 48.1 | 126.2 | 254.4 | 552.7 | 841.2 | 1124.9 | 1123.7 | |
| France, Martinique 26 | 2012 | 162.0 | - | 110.3 | 253.6 | 533.9 | 869.4 | 1272.2 | 1502.9 | 912.6 |
Abbreviations: ASR(w), age-standardized incidence rates (World Population); MENA, Middle East and North Africa; N.B, we included data for the age groups 40 years and above as they are more relevant to the scope of the study.